Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1977 Oct 29;2(6095):1114–1117. doi: 10.1136/bmj.2.6095.1114

Prostaglandin-induced abortion and outcome of subsequent pregnancies: a prospective controlled study

I Z Mackenzie, Keith Hillier
PMCID: PMC1632268  PMID: 338094

Abstract

We analysed a prospective series of 204 pregnancies occurring in 168 women after a prostaglandin-induced abortion. The mean (±standard error of mean) interval between abortion and first subsequent conception was 10·4 ± 0·6 months; no patient reported secondary subfertility.

Fifty-five of the subsequent pregnancies were terminated, 23 during the second trimester, again using prostaglandins. Of the 149 pregnancies not terminated, 127 were delivered at term, and 19 spontaneously aborted, seven during the second trimester; there was one missed abortion and two ectopic pregnancies. Morbidity in the 127 term pregnancies was infrequent; spontaneous preterm labour occurred in three patients, and four singleton infants weighed less than 2500 g at birth. There was no apparent association between morbidity in the subsequent pregnancies and the period of gestation at the time of the previous abortion, route of prostaglandin administration, or need for post-abortion curettage.

The results obtained overall were very similar to a control group of 612 women consecutively admitted for delivery or abortion to the Oxford obstetrical and gynaecological units. There was, however, an increased incidence of spontaneous abortion and placenta praevia after prostaglandin-induced abortion, and the multigravidae in that group had a longer average duration of labour than the control group. Sixty-five per cent of the post-abortion pregnancies were unplanned compared with 36% of the control group.

Full text

PDF
1114

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Daling J. R., Emanuel I. Induced abortion and subsequent outcome of pregnancy. A matched cohort study. Lancet. 1975 Jul 26;2(7926):170–173. doi: 10.1016/s0140-6736(75)90073-2. [DOI] [PubMed] [Google Scholar]
  2. Embrey M. P., Hillier K., Mahendran P. Termination of pregnancy by extraamniotic prostaglandins and the synergistic action of oxytocin. Adv Biosci. 1973;9:507–513. [PubMed] [Google Scholar]
  3. MacKenzie I. Z., Hillier K. Delayed morbidity following prostaglandin-induced abortion. Int J Gynaecol Obstet. 1975;13(5):209–214. doi: 10.1002/j.1879-3479.1975.tb00050.x. [DOI] [PubMed] [Google Scholar]
  4. Mackenzie I. Z., Embrey M. P., Hillier K. Intra-amniotic prostaglandin for induction of abortion: an improved regime using prostaglandin E2. J Obstet Gynaecol Br Commonw. 1974 Jul;81(7):554–557. doi: 10.1111/j.1471-0528.1974.tb00515.x. [DOI] [PubMed] [Google Scholar]
  5. Mackenzie I. Z., Embrey M. P. Single extra-amniotic injection of prostaglandins in viscous gel to induce abortion. Br J Obstet Gynaecol. 1976 Jun;83(6):505–507. doi: 10.1111/j.1471-0528.1976.tb00874.x. [DOI] [PubMed] [Google Scholar]
  6. Mackenzie I. Z., Hillier K., Embrey M. P. Prostaglandin-induced abortion: assessment of operative complications and early morbidity. Br Med J. 1974 Dec 21;4(5946):683–686. doi: 10.1136/bmj.4.5946.683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Richardson J. A., Dixon G. Effects of legal termination on subsequent pregnancy. Br Med J. 1976 May 29;1(6021):1303–1304. doi: 10.1136/bmj.1.6021.1303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Wright C. S., Campbell S., Beazley J. Second-trimester abortion after vaginal termination of pregnancy. Lancet. 1972 Jun 10;1(7763):1278–1279. doi: 10.1016/s0140-6736(72)90995-6. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES